Search Results - Terry-Lorenzo, R.T

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    6LB The Nampt inhibitor MPC-9528 and the PARP inhibitor olaparib synergize in killing a BRCA-deficient cancer cell line

    6LB The Nampt inhibitor MPC-9528 and the PARP inhibitor olaparib synergize in killing a BRCA-deficient cancer cell line by Terry-Lorenzo, R.T, Fleischer, T.C, Lockman, J.W, Boniface, J.J, Willardsen, J.A, Carlson, R.O

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    5LB Anti-tumor activity of MPC-9528, GMX1778 and APO866: Nampt inhibitors of three different structural classes

    5LB Anti-tumor activity of MPC-9528, GMX1778 and APO866: Nampt inhibitors of three different structural classes by Boniface, J.J, Baichwal, V.R, DeMie, L, Green, J.P, Judd, W.R, Lockman, J.W, Papac, D.I, Terry-Lorenzo, R.T, Willardsen, J.A, Carlson, R.O

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: